Overview

Pazopanib for Treating Uterine Leiomyosarcoma

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test any good and bad effects of the study drug pazopanib.
Phase:
Phase 2
Details
Lead Sponsor:
Gynecologic Oncology Group
Collaborator:
GlaxoSmithKline